Page 58 - Read Online

Mu et al. Microstructures 2023;3:2023030 https://dx.doi.org/10.20517/microstructures.2023.05 Page 19 of 21

143. Sage AP, Tintut Y, Demer LL. Regulatory mechanisms in vascular calcification. Nat Rev Cardiol 2010;7:528-36. DOI PubMed
PMC
144. You AYF, Bergholt MS, St-Pierre JP, et al. Raman spectroscopy imaging reveals interplay between atherosclerosis and medial
calcification in the human aorta. Sci Adv 2017;3:e1701156. DOI PubMed PMC
145. Chow B, Rabkin SW. The relationship between arterial stiffness and heart failure with preserved ejection fraction: a systemic meta-
analysis. Heart Fail Rev 2015;20:291-303. DOI PubMed
146. Barasch E, Gottdiener JS, Marino Larsen EK, Chaves PH, Newman AB. Cardiovascular morbidity and mortality in community-
dwelling elderly individuals with calcification of the fibrous skeleton of the base of the heart and aortosclerosis (The Cardiovascular
Health Study). Am J Cardiol 2006;97:1281-6. DOI PubMed
147. Aikawa E, Nahrendorf M, Figueiredo JL, et al. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by
molecular imaging in vivo. Circulation 2007;116:2841-50. DOI
148. Wick G, Grundtman C. Inflammation and atherosclerosis. Boston: Springer Science & Business Media; 2011. DOI
149. Saita A, Bonaccorsi A, Motta M. Stone composition: where do we stand? Urol Int 2007;79 Suppl 1:16-9. DOI PubMed
150. Evan AP, Coe FL, Rittling SR, et al. Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers:
osteopontin localization. Kidney Int 2005;68:145-54. DOI PubMed
151. He JY, Deng SP, Ouyang JM. Morphology, particle size distribution, aggregation, and crystal phase of nanocrystallites in the urine of
healthy persons and lithogenic patients. IEEE Trans Nanobiosci 2010;9:156-63. DOI PubMed
152. Alelign T, Petros B. Kidney stone disease: an update on current concepts. Adv Urol 2018;2018:3068365. DOI PubMed PMC
153. Chaudhary A, Singla SK, Tandon C. In vitro evaluation of terminalia arjuna on calcium phosphate and calcium oxalate
crystallization. Indian J Pharm Sci 2010;72:340-5. PubMed PMC
154. Bensatal A, Ouahrani MR. Inhibition of crystallization of calcium oxalate by the extraction of Tamarix gallica L. Urol Res
2008;36:283-7. DOI PubMed
155. Griffith DP. Struvite stones. Kidney Int 1978;13:372-82. DOI PubMed
156. Luigia M, Summ V. A review of pathological biomineral analysis techniques and classification schemes. In: Aydinalp C, editor. An
introduction to the study of mineralogy. London: InTech; 2012. DOI
157. Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest 2005;115:2598-608. DOI
158. Aggarwal KP, Narula S, Kakkar M, Tandon C. Nephrolithiasis: molecular mechanism of renal stone formation and the critical role
played by modulators. Biomed Res Int 2013;2013:292953. DOI PubMed PMC
159. Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med 1992;327:1141-52. DOI PubMed
160. Fleisch H. Inhibitors and promoters of stone formation. Kidney Int 1978;13:361-71. DOI PubMed
161. Ebrahimpour A, Perez L, Nancollas GH. Induced crystal growth of calcium oxalate monohydrate at hydroxyapatite surfaces. the
influence of human serum albumin, citrate, and magnesium. Langmuir 1991;7:577-83. DOI
162. Asplin JR, Arsenault D, Parks JH, Coe FL, Hoyer JR. Contribution of human uropontin to inhibition of calcium oxalate
crystallization. Kidney Int 1998;53:194-9. DOI PubMed
163. Stapleton A, Ryall U. Blood coagulation proteins and urolithiasis are linked: crystal matrix protein is the Fl activation peptide of
human prothrombin. Br J Urol 1995;75:712-9. DOI
164. Pillay SN, Asplin JR, Coe FL. Evidence that calgranulin is produced by kidney cells and is an inhibitor of calcium oxalate
crystallization. Am J Physiol 1998;275:F255-61. DOI PubMed
165. Loeb JA, Sohrab SA, Huq M, Fuerst DR. Brain calcifications induce neurological dysfunction that can be reversed by a bone drug. J
Neurol Sci 2006;243:77-81. DOI PubMed
166. Smeyers-Verbeke J, Michotte Y, Pelsmaeckers J, et al. The chemical composition of idiopathic nonarteriosclerotic cerebral
calcifications. Neurology 1975;25:48-57. DOI
167. Oliveira JR, Oliveira MF. Primary brain calcification in patients undergoing treatment with the biphosphanate alendronate. Sci Rep
2016;6:22961. DOI PubMed PMC
168. Lemos RR, Ferreira JBMM, Keasey MP, Oliveira JRM. Chapter Fourteen - an update on primary familial brain calcification. In:
Bhatia KP, Schneider SA, editors. International review of neurobiology. Cambridge: Academic Press. 2013; pp. 349-71. DOI
169. Jankovic J. Searching for a relationship between manganese and welding and Parkinson’s disease. Neurology 2005;64:2021-8. DOI
PubMed
170. Bekiesinska-Figatowska M, Mierzewska H, Jurkiewicz E. Basal ganglia lesions in children and adults. Eur J Radiol 2013;82:837-49.
DOI PubMed
171. Simoni M, Pantoni L, Pracucci G, et al. Prevalence of CT-detected cerebral abnormalities in an elderly Swedish population sample.
Acta Neurol Scand 2008;118:260-7. DOI
172. Yamada M, Asano T, Okamoto K, et al. High frequency of calcification in basal ganglia on brain computed tomography images in
Japanese older adults. Geriatr Gerontol Int 2013;13:706-10. DOI
173. Deng H, Zheng W, Jankovic J. Genetics and molecular biology of brain calcification. Ageing Res Rev 2015;22:20-38. DOI
174. Anderson SB, de Souza RF, Hofmann-Rummelt C, Seitz B. Corneal calcification after amniotic membrane transplantation. Br J
Ophthalmol 2003;87:587-91. DOI PubMed PMC
175. Nicholson BP, Lystad LD, Emch TM, Singh AD. Idiopathic dural optic nerve sheath calcification. Br J Ophthalmol 2011;95:290,
299. DOI PubMed